H. Lundbeck A/S Begins Phase II Parkinson's Trial After Phase Ib Data
H. Lundbeck A/S presented Phase Ib data for Lu AF28996 in advanced Parkinson's disease and has initiated a Phase II trial.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
H. Lundbeck A/S presented Phase Ib data for Lu AF28996 in advanced Parkinson's disease and has initiated a Phase II trial.